Prospective Follow-Up of Population with Parkinson's Disease - COPARK Cohort FRESH-PEF60119-en Olivier RASCOL Prospective Follow-Up of Population with Parkinson's Disease - COPARK Cohort COPARK FRESH-PEF60119-en 60119 FRESH-PEF60119 Olivier RASCOL LN PHARMA Epidemiology France Portal (PEF) CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) LN PHARMA ASSOCIATION DE MALADES null Olivier;RASCOL Parkinson's symptoms activities daily life Health episodes quality of life treatment mortality Neurology Biological determinants: Genetic predisposition Biological determinants General objective: The objective of this multi-disciplinary project (neurology, pharmacology, epidemiology etc.) is to prospectively gather data in a population of outpatients with Parkinson's disease identified through a regional network of hospital neurologists and independent physicians, concerning the onset and progression of motor signs (tremor, akinesia, rigidity, motor complications, freezing, falls, dysarthria ...) and non-motor signs (pain, anxiety and depressive symptoms, autonomic dysfunction, sleep disorders, dementia, apathy, fatigue ...) of PD using validated scales. We will also gather data on quality of life, treatment (care sought and consumption of medication), morbidity and mortality within the same population. Secondary objective: To develop a biobank in the second phase based on phenotypic and pharmacological characterisations outlined in the COPARK population null France Nouvelle-Aquitaine Occitanie Hauts-de-France Pays de la Loire Individuals Patients population Male Female Aged (65 to 79 years) Aged, 80 and over (80 years and more) Parkinson's patients with idiopathic Parkinson's disease (UKPDBB criteria) Over 18 years of age, non-institutionalised, with no atypical Parkinsonian syndrome, having never undergone neurosurgery, with no cognitive impairment (MMSE <24), with no serious life-threatening pathology, who have given signed informed consent. Clinical data Participant-reported health data Health event/morbidity Health event/mortality Other Through organizations (health services or institutions schools businesses etc.) < 500 individuals Self-administered questionnaire Interview with the participant (including clinical) Observational Study Observational Study Cohort study 467 Unknown Restricted access Data may be used by academic teams. Data may be used by industrial teams Data access for research members and non-members under contract approved by the cohort Scientific Committee and according to the terms governing the charter between different partners. Access on specific project only